PDL BioPharma Stakeholder, SevenSaoi Capital, Delivers Letter To Board Expressing 'Serious Concerns' Regarding Co.'s Acquisition Strategy; Says Board Must Pursue Alternative Capital Allocation Strategies, Including A 'Significant' Share Repurchase
Benzinga Newsdesk